Nov 10 (Reuters) - Replicel Life Sciences Inc RP.V :
* REPLICEL ANNOUNCES A BINDING TERM SHEET FOR STRATEGIC INVESTMENT AND U.S. PARTNERSHIP
* REPLICEL LIFE SCIENCES INC - INTENT TO ENTER INTO A STRATEGIC PARTNERSHIP WITH MAINPOINTE PHARMACEUTICALS HEADQUARTERED IN LOUISVILLE, KENTUCKY
* REPLICEL LIFE SCIENCES INC - HAS SIGNED A BINDING TERM SHEET WITH MAINPOINTE FOR AN INVESTMENT OF CAD $2.7 MILLION
* REPLICEL LIFE - MAINPOINTE HAS AGREED TO PAY ALL COSTS RELATED TO SECURING FDA APPROVALS TO LAUNCH REPLICEL INJECTOR PRODUCT LINE IN U.S. MARKET